154 related articles for article (PubMed ID: 2649042)
1. Pentoxifylline increases extremity blood flow in diabetic atherosclerotic patients.
Schwartz RW; Logan NM; Johnson PJ; Strodel WE; Fine JG; Kazmers A; Hyde GL
Arch Surg; 1989 Apr; 124(4):434-7. PubMed ID: 2649042
[TBL] [Abstract][Full Text] [Related]
2. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
Perhoniemi V; Salmenkivi K; Sundberg S; Johnsson R; Gordin A
Angiology; 1984 Jun; 35(6):366-72. PubMed ID: 6375469
[TBL] [Abstract][Full Text] [Related]
3. [Use of pentoxifylline in diabetes with intermittent claudication].
Petruzzi E; Bucalossi A; Corri S; Marsilii A; Di Noto C
Ric Clin Lab; 1983; 13 Suppl 3():451-4. PubMed ID: 6673028
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.
Dettelbach HR; Aviado DM
J Clin Pharmacol; 1985; 25(1):8-26. PubMed ID: 3882773
[No Abstract] [Full Text] [Related]
5. Photoplethysmographic documentation of improved microcirculation after pentoxifylline therapy.
Roeren T; LeVeen RF; Nugent L
Angiology; 1988 Nov; 39(11):929-33. PubMed ID: 3177959
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
[TBL] [Abstract][Full Text] [Related]
7. Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
Ehrly AM; Saeger-Lorenz K
Angiology; 1987 Feb; 38(2 Pt 1):93-100. PubMed ID: 3548493
[TBL] [Abstract][Full Text] [Related]
8. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
Gallus AS; Gleadow F; Dupont P; Walsh J; Morley AA; Wenzel A; Alderman M; Chivers D
Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
Gómez Reyes D; Rojas Hidalgo E
Rev Clin Esp; 1988 Jan; 182(1):3-6. PubMed ID: 3375512
[No Abstract] [Full Text] [Related]
11. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
[TBL] [Abstract][Full Text] [Related]
12. [Intermittent claudication treated with pentoxifylline. A controlled trial].
Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Crowder JE; Cohn JB; Savitsky JP; Morgan DL; Slywka J; Cobert BL; Hryniewicki SW; Piccirillo RT; Wilcox CS
Angiology; 1989 Sep; 40(9):795-802. PubMed ID: 2669564
[TBL] [Abstract][Full Text] [Related]
14. Determinants of response to pentoxifylline therapy in patients with intermittent claudication.
Thomas JH; Swannack CJ; McAnaw M; Klein S; Kinnaman ML; Iliopoulos JI; Hermreck AS; Pierce GE
Am J Surg; 1987 Dec; 154(6):663-5. PubMed ID: 3425814
[TBL] [Abstract][Full Text] [Related]
15. Effects and limitations of pentoxifylline therapy in various stages of peripheral vascular disease of the lower extremity.
AbuRahma AF; Woodruff BA
Am J Surg; 1990 Sep; 160(3):266-70. PubMed ID: 2393054
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
[TBL] [Abstract][Full Text] [Related]
17. Another look at the pentoxifylline efficacy data for intermittent claudication.
Gillings D; Koch G; Reich T; Stager WJ
J Clin Pharmacol; 1987 Aug; 27(8):601-9. PubMed ID: 3655008
[TBL] [Abstract][Full Text] [Related]
18. Treatment of claudication with pentoxifylline: are benefits related to improvement in viscosity?
Johnson WC; Sentissi JM; Baldwin D; Hamilton J; Dion J
J Vasc Surg; 1987 Sep; 6(3):211-6. PubMed ID: 3625877
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline--a new drug for the treatment of intermittent claudication.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline and claudication.
Johnson G
J Vasc Surg; 1988 Nov; 8(5):649. PubMed ID: 3184319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
